Innovative Research Award
Alessandro Allegra,
Università di Messina.
Alessandro Allegra is a researcher affiliated with the Università di Messina whose published work includes studies in hematology, immunology, oncology, inflammatory signaling, oxidative stress, and related biomedical fields. His documented scholarly record includes substantial publication activity and citation impact, while his ORCID and Scopus identifiers provide persistent mechanisms for research-profile identification.[1][2]
Abstract
Alessandro Allegra’s academic profile reflects sustained research activity at the intersection of hematology, immunology, oncology, inflammation, and molecular mechanisms relevant to disease. His scholarly record includes 354 documents, 7,159 citations, and an h-index of 43 as supplied for this recognition profile. Published studies address topics including immune checkpoint regulation, redox signaling, multiple myeloma, cytokine activity, and molecular pathways. Several indexed publications demonstrate interdisciplinary collaboration and application of experimental and analytical approaches to biomedical questions.[1][3][4]
Keywords
Alessandro Allegra; immunology; hematology; oncology; multiple myeloma; redox signaling; oxidative stress; cytokines; immune checkpoint inhibitors; molecular medicine; biomedical research; Università di Messina; research impact.
Introduction
Alessandro Allegra is affiliated with the Università di Messina and has contributed to biomedical research spanning hematology, immunology, oncology, inflammation, and molecular mechanisms of disease. His published work includes investigations of immune regulation, multiple myeloma, oxidative and redox processes, and therapeutic pathways, reflecting a multidisciplinary research orientation.[1][3]
Research Profile
The research profile associated with Allegra encompasses hematological disorders, immunological responses, inflammatory signaling, cancer biology, and molecular mechanisms. Published studies identify the University of Messina as a recurring institutional affiliation and document collaborative research with investigators across related biomedical disciplines. His supplied Scopus record lists 354 documents, 7,159 citations, and an h-index of 43.[1][5]
Research Contributions
Documented contributions include research on cytokine balance in multiple myeloma, long noncoding RNA expression, alarmins, redox regulation, and immune checkpoint activity. These studies examine biological mechanisms associated with hematological malignancies and cancer-related immune responses. The published record also demonstrates collaborative investigation involving clinical, molecular, and translational perspectives across biomedical research.[3][4][5]
Publications
Selected publications illustrate the breadth of Allegra’s research. Recent examples include work on redox signaling and immune checkpoint inhibitors in cancer patients, while earlier studies examined redox regulation in acute leukemia and cytokine-mediated mechanisms in multiple myeloma. His publication record also includes molecular studies of long noncoding RNA and disease-associated signaling pathways.[3][4]
Research Impact
The supplied bibliometric profile reports 7,159 citations and an h-index of 43 across 354 documents, indicating a substantial indexed publication and citation record. Individual publications have also accumulated citations through subsequent scholarly literature. For example, the 2020 study on long noncoding RNA expression is indexed with citation information through its publisher record.[1][5]
Award Suitability
The supplied academic record provides documented indicators relevant to consideration for the Innovative Research Award, including a substantial publication portfolio, citation activity, and interdisciplinary research addressing immunological and biomedical questions. His publications demonstrate investigations across molecular mechanisms, disease biology, inflammation, and therapeutic research. These documented characteristics provide an academic basis for recognition under the stated award category.[1][3][4]
Conclusion
Alessandro Allegra’s documented research record encompasses hematology, immunology, oncology, inflammation, and molecular medicine. His publications address diverse biomedical questions and include DOI-indexed studies in established journals. The supplied bibliometric indicators further describe an extensive scholarly record. Collectively, these documented elements provide a structured basis for presenting his research profile within the Innovative Research Award context.[1][3][4]
External Links
References
- Allegra, A., Murdaca, G., Mirabile, G., & Gangemi, S. (2023). Redox Signaling Modulates Activity of Immune Checkpoint Inhibitors in Cancer Patients. Biomedicines, 11(5), 1325. DOI: 10.3390/biomedicines11051325.
https://doi.org/10.3390/biomedicines11051325
- Allegra, A., Tonacci, A., Giordano, L., Musolino, C., & Gangemi, S. (2022). Targeting Redox Regulation as a Therapeutic Opportunity against Acute Leukemia: Pro-Oxidant Strategy or Antioxidant Approach? Antioxidants, 11(9), 1696. DOI: 10.3390/antiox11091696.
https://doi.org/10.3390/antiox11091696
- Murdaca, G., Allegra, A., Paladin, F., Calapai, F., Musolino, C., & Gangemi, S. (2021). Involvement of Alarmins in the Pathogenesis and Progression of Multiple Myeloma. International Journal of Molecular Sciences, 22(16), 9039. DOI: 10.3390/ijms22169039.
https://doi.org/10.3390/ijms22169039
- Musolino, C., Allegra, A., Innao, V., Allegra, A. G., Pioggia, G., & Gangemi, S. (2017). Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma. Mediators of Inflammation, 2017, 1852517. DOI: 10.1155/2017/1852517.
https://doi.org/10.1155/2017/1852517
- Allegra, A., Mania, M., D’Ascola, A., Oteri, G., Nastro, E., Avenoso, A., Innao, V., Allegra, A. G., Scuruchi, M., Musolino, C., & Campo, S. (2020). Altered Long Noncoding RNA Expression Profile in Multiple Myeloma Patients with Bisphosphonate-Induced Osteonecrosis of the Jaw. BioMed Research International, 2020, 9879876. DOI: 10.1155/2020/9879876.
https://doi.org/10.1155/2020/9879876